Next Article in Journal
DNA Methylation in Thyroid Tumorigenesis
Next Article in Special Issue
Biomarkers in Advanced Colorectal Cancer: Challenges in Translating Clinical Research into Practice
Previous Article in Journal
Epigenetics of Estrogen Receptor Signaling: Role in Hormonal Cancer Progression and Therapy
Previous Article in Special Issue
Predictive and Prognostic Factors in Colorectal Cancer: A Personalized Approach
Cancers 2011, 3(2), 1708-1731; doi:10.3390/cancers3021708

Regulatory T Cells in Colorectal Cancer: From Biology to Prognostic Relevance

Department of Oncology and Pathology, Immune and Gene Therapy Unit, Cancer Centre Karolinska, CCK R8:01, 17176 Stockholm, Sweden
Received: 4 February 2010 / Revised: 13 March 2011 / Accepted: 21 March 2011 / Published: 29 March 2011
(This article belongs to the Special Issue Prognostic and Predictive Factors in Colorectal Cancer)
View Full-Text   |   Download PDF [273 KB, 30 March 2011; original version 29 March 2011]   |   Browse Figures


Regulatory T cells (Tregs) were initially described as "suppressive" lymphocytes in the 1980s. However, it took almost 20 years until the concept of Treg-mediated immune control in its present form was finally established. Tregs are obligatory for self-tolerance and defects within their population lead to severe autoimmune disorders. On the other hand Tregs may promote tolerance for tumor antigens and even hamper efforts to overcome it. Intratumoral and systemic accumulation of Tregs has been observed in various types of cancer and is often linked to worse disease course and outcome. Increase of circulating Tregs, as well as their presence in mesenteric lymph nodes and tumor tissue of patients with colorectal cancer de facto suggests a strong involvement of Tregs in the antitumor control. This review will focus on the Treg biology in view of colorectal cancer, means of Treg accumulation and the controversies regarding their prognostic significance. In addition, a concise overview will be given on how Tregs and their function can be targeted in cancer patients in order to bolster an inherent immune response and/or increase the efficacy of immunotherapeutic approaches.
Keywords: regulatory T cells; colorectal cancer; prognostic marker; immune escape regulatory T cells; colorectal cancer; prognostic marker; immune escape
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Mougiakakos, D. Regulatory T Cells in Colorectal Cancer: From Biology to Prognostic Relevance. Cancers 2011, 3, 1708-1731.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert